Immunomodulatory effects of mesoporous silica nanoparticles on osteogenesis: From nanoimmunotoxicity to nanoimmunotherapy
Source abstract
Abstract
The immune reaction towards nanomaterials has long been concerned for the safety issue. A concept “nanoimmunotoxicity” was generated accordingly to describe this deleterious immunomodulatory effects. In additional to the detrimental effects, immune response has also been proved to be an essential component of the biomaterials-mediated reconstruction of a functional tissue. In this study, we investigate the immunomodualtory effects of mesoporous silica nanoparticles (MSNs) on macrophages and the effects of the generated osteoimmune environment on bone marrow mesenchymal stromal cells. It is found that macrophages could uptake MSNs and elicited significant effects on inhibiting the inflammatory response, which could be due to the inhibition of Wnt5A/Ca pathway and the activation of autophagy. Interestingly, the modulated immune environment enhanced the osteogenic differentiation of bone marrow mesenchymal stromal cells, leading to the increase of mineralized nodules and alkaline phosphatase activity. This suggests that the immunomodulatory effects of nanomaterials are not always detrimental, but can be beneficial for tissue regeneration. In addition to the detrimental effects, the positive effects of nanomaterial-mediated immune response should be emphasized. The concept “nanoimmumotherpy” was proposed accordingly, and the paradigm on design nanomaterials should be shifted from “inert” to “immunomoluatory” to modulate an immune environment favourable for tissue regeneration and therapy.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · RNA Interference and Gene Delivery · Bone Metabolism and Diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (49)
Show source-provided references
1. Nanomaterials for engineering stem cell responses10.1002/adhm.201500272 ↗
2. Metal oxide nanoparticles as versatile therapeutic agents modulating cell signaling pathways: linking nanotechnology with molecular medicine10.1016/j.apmt.2017.01.010 ↗
3. Investigating the potential of combined growth factors delivery, from non-mulberry silk fibroin grafted poly(ɛ-caprolactone)/hydroxyapatite nanofibrous scaffold, in bone tissue engineering10.1016/j.apmt.2016.09.007 ↗
4. Development of nanomaterials for bone repair and regeneration10.1002/jbm.b.32823 ↗
5. Engineering biomaterials to integrate and heal: the biocompatibility paradigm shifts10.1002/bit.24559 ↗
6. Immune responses to implants – a review of the implications for the design of immunomodulatory biomaterials10.1016/j.biomaterials.2011.05.078 ↗
7. On the nature of biomaterials10.1016/j.biomaterials.2009.07.027 ↗
8. A perspective on immunomodulation and tissue repair10.1007/s10439-013-0941-0 ↗
9. Copper-doped mesoporous silica nanospheres, a promising immunomodulatory agent for inducing osteogenesis10.1016/j.actbio.2015.11.033 ↗
10. Tuning chemistry and topography of nanoengineered surfaces to manipulate immune response for bone regeneration applications10.1021/acsnano.6b07808 ↗
11. Nanoporous microstructures mediate osteogenesis by modulating the osteo-immune response of macrophages10.1039/C6NR06421C ↗
12. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems10.1038/nri2062 ↗
13. Osteoimmunology: interplay between the immune system and bone metabolism10.1146/annurev.immunol.24.021605.090646 ↗
14. Molecularly organic/inorganic hybrid hollow mesoporous organosilica nanocapsules with tumor-specific biodegradability and enhanced chemotherapeutic functionality10.1016/j.biomaterials.2017.02.018 ↗
15. Metalloporphyrin-encapsulated biodegradable nanosystems for highly efficient magnetic resonance imaging-guided sonodynamic cancer therapy10.1021/jacs.6b11846 ↗
16. Graphene quantum dots-capped magnetic mesoporous silica nanoparticles as a multifunctional platform for controlled drug delivery, magnetic hyperthermia, and photothermal therapy10.1002/smll.201602225 ↗
17. Immune response to nanomaterials: implications for medicine and literature review10.1007/s11882-012-0302-3 ↗
18. Nanoparticle hydrophobicity dictates immune response10.1021/ja2108905 ↗
19. Autophagy in macrophages: impacting inflammation and bacterial infection
20. Bioactive silica nanoparticles promote osteoblast differentiation through stimulation of autophagy and direct association with LC3 and p6210.1021/nn5009879 ↗
21. In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles10.1002/adma.201205292 ↗
22. Osteoimmunomodulatory properties of magnesium scaffolds coated with beta-tricalcium phosphate10.1016/j.biomaterials.2014.06.038 ↗
23. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy10.1073/pnas.0712145105 ↗
24. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles10.1016/j.biomaterials.2010.01.065 ↗
25. Hirota · 2012
26. Endocytosis conducts the cell signaling orchestra10.1016/j.cell.2006.02.025 ↗
27. The comparative immunotoxicity of mesoporous silica nanoparticles and colloidal silica nanoparticles in mice
28. The comparative effects of mesoporous silica nanoparticles and colloidal silica on inflammation and apoptosis10.1016/j.biomaterials.2011.08.042 ↗
29. Wnt5a promotes inflammatory responses via nuclear factor κB (NF-κB) and mitogen-activated protein kinase (MAPK) pathways in human dental pulp cells10.1074/jbc.M113.546523 ↗
30. Wnt pathway: a new role in regulation of inflammation10.1161/ATVBAHA.107.160952 ↗
31. Wnt/Ca2+ signaling pathway: a brief overview10.1093/abbs/gmr079 ↗
32. The effect of silicate ions on proliferation, osteogenic differentiation and cell signalling pathways (WNT and SHH) of bone marrow stromal cells10.1039/C2BM00108J ↗
33. Multiple mechanisms for Wnt11-mediated repression of the canonical Wnt signaling pathway10.1074/jbc.M311724200 ↗
34. Impaired macrophage autophagy increases the immune response in obese mice by promoting proinflammatory macrophage polarization10.1080/15548627.2015.1009787 ↗
35. Stimulation of autophagy prevents intestinal mucosal inflammation and ameliorates murine colitis10.1111/bph.13860 ↗
36. Autophagy-mediated regulation of macrophages and its applications for cancer10.4161/auto.26927 ↗
37. Selective autophagy of the adaptor protein Bcl10 modulates T cell receptor activation of NF-kappaB10.1016/j.immuni.2012.04.008 ↗
38. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1[bgr] production10.1038/nature07383 ↗
39. Shared principles in NF-kappaB signaling10.1016/j.cell.2008.01.020 ↗
40. The noncanonical NF-kappaB pathway10.1111/j.1600-065X.2011.01088.x ↗
41. The stimulation of osteogenic differentiation of human adipose-derived stem cells by ionic products from akermanite dissolution via activation of the ERK pathway10.1016/j.biomaterials.2011.06.003 ↗
42. A multifunctional bioactive material that stimulates osteogenesis and promotes the vascularization bone marrow stem cells and their resistance to bacterial infection10.1371/journal.pone.0172499 ↗
43. Biological responses of human bone marrow mesenchymal stem cells to Sr-M-Si (M=Zn, Mg) silicate bioceramics10.1002/jbm.a.34246 ↗
44. Biological silicon stimulates collagen type 1 and osteocalcin synthesis in human osteoblast-like cells through the BMP-2/Smad/RUNX2 signaling pathway10.1007/s12011-016-0686-3 ↗
45. Si and Ca individually and combinatorially target enhanced MC3T3-E1 subclone 4 early osteogenic marker expression10.1563/AAID-JOI-D-11-00108 ↗
46. Macrophage cell lines produce osteoinductive signals that include bone morphogenetic protein-210.1016/S8756-3282(01)00638-X ↗
47. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway10.1677/JOE-07-0532 ↗
48. Inhibition of osteoblast differentiation by tumor necrosis factor-alpha10.1210/endo.141.11.7739 ↗
49. Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-gamma and TNF-alpha10.1038/nm.2542 ↗